Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invibio Biomaterial Solutions, a subsidiary of Victrex plc, is a global leader in the development and manufacture of high-performance polymer solutions for the medical device industry. The company is best known for its PEEK-OPTIMA™ polymers, which have become a gold standard for long-term implantable medical devices due to their biocompatibility, radiolucency, and mechanical properties similar to human bone. Invibio provides a comprehensive range of biomaterials, including carbon fiber-reinforced and hydroxyapatite-enhanced PEEK, tailored for applications in spine, orthopedics, trauma, dental, and cardiovascular markets. Beyond material supply, the company offers extensive technical, manufacturing, and regulatory support to help medical device manufacturers accelerate their product development cycles. With millions of devices implanted worldwide, Invibio's technologies are critical to advancing clinical outcomes and patient quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invibio Biomaterial Solutions.